Centre d'Information et de documentation du CRA Rhône-Alpes
CRA
Informations pratiques
-
Adresse
Centre d'information et de documentation
du CRA Rhône-Alpes
Centre Hospitalier le Vinatier
bât 211
95, Bd Pinel
69678 Bron CedexHoraires
Lundi au Vendredi
9h00-12h00 13h30-16h00Contact
Tél: +33(0)4 37 91 54 65
Mail
Fax: +33(0)4 37 91 54 37
-
Détail de l'auteur
Auteur Michael G. AMAN |
Documents disponibles écrits par cet auteur (22)
Faire une suggestion Affiner la recherche
A Longitudinal Investigation of Psychotropic and Non-Psychotropic Medication Use Among Adolescents and Adults with Autism Spectrum Disorders / Anna J. ESBENSEN in Journal of Autism and Developmental Disorders, 39-9 (September 2009)
[article]
Titre : A Longitudinal Investigation of Psychotropic and Non-Psychotropic Medication Use Among Adolescents and Adults with Autism Spectrum Disorders Type de document : Texte imprimé et/ou numérique Auteurs : Anna J. ESBENSEN, Auteur ; Michael G. AMAN, Auteur ; Marsha MAILICK SELTZER, Auteur ; Jan S. GREENBERG, Auteur Année de publication : 2009 Article en page(s) : p.1339-1349 Langues : Anglais (eng) Mots-clés : ASD Medication Psychotropic-medication Non-psychotropic-medication Index. décimale : PER Périodiques Résumé : Medication use was examined in 286 adolescents and adults with ASD over a 4.5 year period. A total of 70% were taking a psychotropic or non-psychotropic medication at the beginning of the study. Both the number of psychotropic and non-psychotropic medications taken, and the proportion of individuals taking these medications, increased significantly over the study period, with 81% taking at least one medication 4.5 years later. Our findings suggested a high likelihood of staying medicated over time. Thus, adolescents and adults with ASD are a highly and increasingly medicated population. En ligne : http://dx.doi.org/10.1007/s10803-009-0750-3 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=815
in Journal of Autism and Developmental Disorders > 39-9 (September 2009) . - p.1339-1349[article] A Longitudinal Investigation of Psychotropic and Non-Psychotropic Medication Use Among Adolescents and Adults with Autism Spectrum Disorders [Texte imprimé et/ou numérique] / Anna J. ESBENSEN, Auteur ; Michael G. AMAN, Auteur ; Marsha MAILICK SELTZER, Auteur ; Jan S. GREENBERG, Auteur . - 2009 . - p.1339-1349.
Langues : Anglais (eng)
in Journal of Autism and Developmental Disorders > 39-9 (September 2009) . - p.1339-1349
Mots-clés : ASD Medication Psychotropic-medication Non-psychotropic-medication Index. décimale : PER Périodiques Résumé : Medication use was examined in 286 adolescents and adults with ASD over a 4.5 year period. A total of 70% were taking a psychotropic or non-psychotropic medication at the beginning of the study. Both the number of psychotropic and non-psychotropic medications taken, and the proportion of individuals taking these medications, increased significantly over the study period, with 81% taking at least one medication 4.5 years later. Our findings suggested a high likelihood of staying medicated over time. Thus, adolescents and adults with ASD are a highly and increasingly medicated population. En ligne : http://dx.doi.org/10.1007/s10803-009-0750-3 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=815 Measuring Anxiety as a Treatment Endpoint in Youth with Autism Spectrum Disorder / Luc LECAVALIER in Journal of Autism and Developmental Disorders, 44-5 (May 2014)
[article]
Titre : Measuring Anxiety as a Treatment Endpoint in Youth with Autism Spectrum Disorder Type de document : Texte imprimé et/ou numérique Auteurs : Luc LECAVALIER, Auteur ; Jeffrey J. WOOD, Auteur ; Alycia K. HALLADAY, Auteur ; Nancy E. JONES, Auteur ; Michael G. AMAN, Auteur ; Edwin H. Jr COOK, Auteur ; Benjamin L. HANDEN, Auteur ; Bryan H. KING, Auteur ; Deborah A. PEARSON, Auteur ; Victoria HALLETT, Auteur ; Katherine Anne SULLIVAN, Auteur ; Sabrina N. GRONDHUIS, Auteur ; Somer L. BISHOP, Auteur ; Joseph P. HORRIGAN, Auteur ; Geraldine DAWSON, Auteur ; Lawrence SCAHILL, Auteur Année de publication : 2014 Article en page(s) : p.1128-1143 Langues : Anglais (eng) Mots-clés : Autism spectrum disorder Anxiety Instrument Measure Assessment Treatment Intervention Index. décimale : PER Périodiques Résumé : Despite the high rate of anxiety in individuals with autism spectrum disorder (ASD), measuring anxiety in ASD is fraught with uncertainty. This is due, in part, to incomplete consensus on the manifestations of anxiety in this population. Autism Speaks assembled a panel of experts to conduct a systematic review of available measures for anxiety in youth with ASD. To complete the review, the panel held monthly conference calls and two face-to-face meetings over a fourteen-month period. Thirty eight published studies were reviewed and ten assessment measures were examined: four were deemed appropriate for use in clinical trials, although with conditions; three were judged to be potentially appropriate, while three were considered not useful for clinical trials assessing anxiety. Despite recent advances, additional relevant, reliable and valid outcome measures are needed to evaluate treatments for anxiety in ASD. En ligne : http://dx.doi.org/10.1007/s10803-013-1974-9 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=232
in Journal of Autism and Developmental Disorders > 44-5 (May 2014) . - p.1128-1143[article] Measuring Anxiety as a Treatment Endpoint in Youth with Autism Spectrum Disorder [Texte imprimé et/ou numérique] / Luc LECAVALIER, Auteur ; Jeffrey J. WOOD, Auteur ; Alycia K. HALLADAY, Auteur ; Nancy E. JONES, Auteur ; Michael G. AMAN, Auteur ; Edwin H. Jr COOK, Auteur ; Benjamin L. HANDEN, Auteur ; Bryan H. KING, Auteur ; Deborah A. PEARSON, Auteur ; Victoria HALLETT, Auteur ; Katherine Anne SULLIVAN, Auteur ; Sabrina N. GRONDHUIS, Auteur ; Somer L. BISHOP, Auteur ; Joseph P. HORRIGAN, Auteur ; Geraldine DAWSON, Auteur ; Lawrence SCAHILL, Auteur . - 2014 . - p.1128-1143.
Langues : Anglais (eng)
in Journal of Autism and Developmental Disorders > 44-5 (May 2014) . - p.1128-1143
Mots-clés : Autism spectrum disorder Anxiety Instrument Measure Assessment Treatment Intervention Index. décimale : PER Périodiques Résumé : Despite the high rate of anxiety in individuals with autism spectrum disorder (ASD), measuring anxiety in ASD is fraught with uncertainty. This is due, in part, to incomplete consensus on the manifestations of anxiety in this population. Autism Speaks assembled a panel of experts to conduct a systematic review of available measures for anxiety in youth with ASD. To complete the review, the panel held monthly conference calls and two face-to-face meetings over a fourteen-month period. Thirty eight published studies were reviewed and ten assessment measures were examined: four were deemed appropriate for use in clinical trials, although with conditions; three were judged to be potentially appropriate, while three were considered not useful for clinical trials assessing anxiety. Despite recent advances, additional relevant, reliable and valid outcome measures are needed to evaluate treatments for anxiety in ASD. En ligne : http://dx.doi.org/10.1007/s10803-013-1974-9 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=232 Measuring repetitive behaviors as a treatment endpoint in youth with autism spectrum disorder / Lawrence SCAHILL in Autism, 19-1 (January 2015)
[article]
Titre : Measuring repetitive behaviors as a treatment endpoint in youth with autism spectrum disorder Type de document : Texte imprimé et/ou numérique Auteurs : Lawrence SCAHILL, Auteur ; Michael G. AMAN, Auteur ; Luc LECAVALIER, Auteur ; Alycia K. HALLADAY, Auteur ; Somer L. BISHOP, Auteur ; James W. BODFISH, Auteur ; Sabrina GRONDHUIS, Auteur ; Nancy JONES, Auteur ; Joseph P. HORRIGAN, Auteur ; Edwin H. Jr COOK, Auteur ; Benjamin L. HANDEN, Auteur ; Bryan H. KING, Auteur ; Deborah A. PEARSON, Auteur ; James T. MCCRACKEN, Auteur ; Katherine Anne SULLIVAN, Auteur ; Geraldine DAWSON, Auteur Année de publication : 2015 Article en page(s) : p.38-52 Langues : Anglais (eng) Mots-clés : Assessment autism spectrum disorders instrument intervention repetitive behavior restricted interests measure treatment; Index. décimale : PER Périodiques Résumé : Restricted interests and repetitive behaviors vary widely in type, frequency, and intensity among children and adolescents with autism spectrum disorder. They can be stigmatizing and interfere with more constructive activities. Accordingly, restricted interests and repetitive behaviors may be a target of intervention. Several standardized instruments have been developed to assess restricted interests and repetitive behaviors in the autism spectrum disorder population, but the rigor of psychometric assessment is variable. This article evaluated the readiness of available measures for use as outcome measures in clinical trials. The Autism Speaks Foundation assembled a panel of experts to examine available instruments used to measure restricted interests and repetitive behaviors in youth with autism spectrum disorder. The panel held monthly conference calls and two face-to-face meetings over 14 months to develop and apply evaluative criteria for available instruments. Twenty-four instruments were evaluated and five were considered “appropriate with conditions” for use as outcome measures in clinical trials. Ideally, primary outcome measures should be relevant to the clinical target, be reliable and valid, and cover the symptom domain without being burdensome to subjects. The goal of the report was to promote consensus across funding agencies, pharmaceutical companies, and clinical investigators about advantages and disadvantages of existing outcome measures. En ligne : http://dx.doi.org/10.1177/1362361313510069 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=245
in Autism > 19-1 (January 2015) . - p.38-52[article] Measuring repetitive behaviors as a treatment endpoint in youth with autism spectrum disorder [Texte imprimé et/ou numérique] / Lawrence SCAHILL, Auteur ; Michael G. AMAN, Auteur ; Luc LECAVALIER, Auteur ; Alycia K. HALLADAY, Auteur ; Somer L. BISHOP, Auteur ; James W. BODFISH, Auteur ; Sabrina GRONDHUIS, Auteur ; Nancy JONES, Auteur ; Joseph P. HORRIGAN, Auteur ; Edwin H. Jr COOK, Auteur ; Benjamin L. HANDEN, Auteur ; Bryan H. KING, Auteur ; Deborah A. PEARSON, Auteur ; James T. MCCRACKEN, Auteur ; Katherine Anne SULLIVAN, Auteur ; Geraldine DAWSON, Auteur . - 2015 . - p.38-52.
Langues : Anglais (eng)
in Autism > 19-1 (January 2015) . - p.38-52
Mots-clés : Assessment autism spectrum disorders instrument intervention repetitive behavior restricted interests measure treatment; Index. décimale : PER Périodiques Résumé : Restricted interests and repetitive behaviors vary widely in type, frequency, and intensity among children and adolescents with autism spectrum disorder. They can be stigmatizing and interfere with more constructive activities. Accordingly, restricted interests and repetitive behaviors may be a target of intervention. Several standardized instruments have been developed to assess restricted interests and repetitive behaviors in the autism spectrum disorder population, but the rigor of psychometric assessment is variable. This article evaluated the readiness of available measures for use as outcome measures in clinical trials. The Autism Speaks Foundation assembled a panel of experts to examine available instruments used to measure restricted interests and repetitive behaviors in youth with autism spectrum disorder. The panel held monthly conference calls and two face-to-face meetings over 14 months to develop and apply evaluative criteria for available instruments. Twenty-four instruments were evaluated and five were considered “appropriate with conditions” for use as outcome measures in clinical trials. Ideally, primary outcome measures should be relevant to the clinical target, be reliable and valid, and cover the symptom domain without being burdensome to subjects. The goal of the report was to promote consensus across funding agencies, pharmaceutical companies, and clinical investigators about advantages and disadvantages of existing outcome measures. En ligne : http://dx.doi.org/10.1177/1362361313510069 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=245 A multisite trial of atomoxetine and parent training in children with autism spectrum disorders: Rationale and design challenges / Laura SILVERMAN in Research in Autism Spectrum Disorders, 8-7 (July 2014)
[article]
Titre : A multisite trial of atomoxetine and parent training in children with autism spectrum disorders: Rationale and design challenges Type de document : Texte imprimé et/ou numérique Auteurs : Laura SILVERMAN, Auteur ; Jill A. HOLLWAY, Auteur ; Tristram SMITH, Auteur ; Michael G. AMAN, Auteur ; L. Eugene ARNOLD, Auteur ; Xueliang PAN, Auteur ; Xiaobai LI, Auteur ; Benjamin L. HANDEN, Auteur Article en page(s) : p.899-907 Langues : Anglais (eng) Mots-clés : Atomoxetine (Strattera) ADHD Autism spectrum disorder Drug trial Parent training Index. décimale : PER Périodiques Résumé : Abstract Several randomized controlled trials (RCTs) involving children with autism spectrum disorder (ASD) have examined effectiveness of mono-therapies for problem behavior. However, results have not been as encouraging as in typically developing children. For example, when prescribed stimulants, children with ASD and hyperactivity/inattentiveness, show only moderately reduced symptoms, with frequent side effects. Therefore, alternative treatments or combinations of treatments are needed. The Children's Hyperactivity and Autism Research Treatment Study (CHARTS) is a randomized clinical trial comparing the individual and combined effects of atomoxetine and parent training to treat hyperactivity, inattentiveness, and noncompliance in children with ASD. Design challenges included the overall study design, targeting of different outcomes by different treatments, and data analysis. This article details options for addressing a number of these methodological issues in the context of conducting a large multicenter RCT with an ASD population. En ligne : http://dx.doi.org/10.1016/j.rasd.2014.03.013 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=233
in Research in Autism Spectrum Disorders > 8-7 (July 2014) . - p.899-907[article] A multisite trial of atomoxetine and parent training in children with autism spectrum disorders: Rationale and design challenges [Texte imprimé et/ou numérique] / Laura SILVERMAN, Auteur ; Jill A. HOLLWAY, Auteur ; Tristram SMITH, Auteur ; Michael G. AMAN, Auteur ; L. Eugene ARNOLD, Auteur ; Xueliang PAN, Auteur ; Xiaobai LI, Auteur ; Benjamin L. HANDEN, Auteur . - p.899-907.
Langues : Anglais (eng)
in Research in Autism Spectrum Disorders > 8-7 (July 2014) . - p.899-907
Mots-clés : Atomoxetine (Strattera) ADHD Autism spectrum disorder Drug trial Parent training Index. décimale : PER Périodiques Résumé : Abstract Several randomized controlled trials (RCTs) involving children with autism spectrum disorder (ASD) have examined effectiveness of mono-therapies for problem behavior. However, results have not been as encouraging as in typically developing children. For example, when prescribed stimulants, children with ASD and hyperactivity/inattentiveness, show only moderately reduced symptoms, with frequent side effects. Therefore, alternative treatments or combinations of treatments are needed. The Children's Hyperactivity and Autism Research Treatment Study (CHARTS) is a randomized clinical trial comparing the individual and combined effects of atomoxetine and parent training to treat hyperactivity, inattentiveness, and noncompliance in children with ASD. Design challenges included the overall study design, targeting of different outcomes by different treatments, and data analysis. This article details options for addressing a number of these methodological issues in the context of conducting a large multicenter RCT with an ASD population. En ligne : http://dx.doi.org/10.1016/j.rasd.2014.03.013 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=233 Overweight and obese status in children with autism spectrum disorder and disruptive behavior / K. K. CRIADO in Autism, 22-4 (May 2018)
[article]
Titre : Overweight and obese status in children with autism spectrum disorder and disruptive behavior Type de document : Texte imprimé et/ou numérique Auteurs : K. K. CRIADO, Auteur ; W. G. SHARP, Auteur ; C. E. MCCRACKEN, Auteur ; O. DE VINCK-BAROODY, Auteur ; L. DONG, Auteur ; Michael G. AMAN, Auteur ; C. J. MCDOUGLE, Auteur ; J. T. MCCRACKEN, Auteur ; L. EUGENE ARNOLD, Auteur ; C. WEITZMAN, Auteur ; J. M. LEVENTHAL, Auteur ; B. VITIELLO, Auteur ; Lawrence SCAHILL, Auteur Article en page(s) : p.450-459 Langues : Anglais (eng) Mots-clés : National Health and Nutrition Examination Surveys prevalence risperidone Index. décimale : PER Périodiques Résumé : Overweight and obesity are common in pediatric populations. Children with autism spectrum disorder and disruptive behavior may be at higher risk. This study examined whether children with autism spectrum disorder and disruptive behavior are more likely to be overweight or obese than matched controls. Baseline data from medication-free children with autism spectrum disorder who participated in trials conducted by the Research Units on Pediatric Psychopharmacology Autism Network (N = 276) were compared to 544 control children from the National Health and Nutrition Examination Survey database matched on age, sex, race, parent education, and era of data collection. The mean age of the children with autism spectrum disorder was 7.9 +/- 2.6 years; 84.4% were males. In the autism spectrum disorder group, the prevalence was 42.4% for overweight and 21.4% for obesity compared to 26.1% for overweight and 12.0% for obesity among controls (p < 0.001 for each contrast). Within the autism spectrum disorder sample, obesity was associated with minority status and lower daily living skills. These findings suggest that children with autism spectrum disorder and disruptive behavior are at increased risk for obesity and underscore the need for weight management interventions in this population. En ligne : http://dx.doi.org/10.1177/1362361316683888 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=361
in Autism > 22-4 (May 2018) . - p.450-459[article] Overweight and obese status in children with autism spectrum disorder and disruptive behavior [Texte imprimé et/ou numérique] / K. K. CRIADO, Auteur ; W. G. SHARP, Auteur ; C. E. MCCRACKEN, Auteur ; O. DE VINCK-BAROODY, Auteur ; L. DONG, Auteur ; Michael G. AMAN, Auteur ; C. J. MCDOUGLE, Auteur ; J. T. MCCRACKEN, Auteur ; L. EUGENE ARNOLD, Auteur ; C. WEITZMAN, Auteur ; J. M. LEVENTHAL, Auteur ; B. VITIELLO, Auteur ; Lawrence SCAHILL, Auteur . - p.450-459.
Langues : Anglais (eng)
in Autism > 22-4 (May 2018) . - p.450-459
Mots-clés : National Health and Nutrition Examination Surveys prevalence risperidone Index. décimale : PER Périodiques Résumé : Overweight and obesity are common in pediatric populations. Children with autism spectrum disorder and disruptive behavior may be at higher risk. This study examined whether children with autism spectrum disorder and disruptive behavior are more likely to be overweight or obese than matched controls. Baseline data from medication-free children with autism spectrum disorder who participated in trials conducted by the Research Units on Pediatric Psychopharmacology Autism Network (N = 276) were compared to 544 control children from the National Health and Nutrition Examination Survey database matched on age, sex, race, parent education, and era of data collection. The mean age of the children with autism spectrum disorder was 7.9 +/- 2.6 years; 84.4% were males. In the autism spectrum disorder group, the prevalence was 42.4% for overweight and 21.4% for obesity compared to 26.1% for overweight and 12.0% for obesity among controls (p < 0.001 for each contrast). Within the autism spectrum disorder sample, obesity was associated with minority status and lower daily living skills. These findings suggest that children with autism spectrum disorder and disruptive behavior are at increased risk for obesity and underscore the need for weight management interventions in this population. En ligne : http://dx.doi.org/10.1177/1362361316683888 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=361 Parent Stress in a Randomized Clinical Trial of Atomoxetine and Parent Training for Children with Autism Spectrum Disorder / L. LECAVALIER in Journal of Autism and Developmental Disorders, 48-4 (April 2018)
PermalinkPositive Effects of Methylphenidate on Social Communication and Self-Regulation in Children with Pervasive Developmental Disorders and Hyperactivity / Laudan B. JAHROMI in Journal of Autism and Developmental Disorders, 39-3 (March 2009)
PermalinkPredictors and Moderators of Parent Training Efficacy in a Sample of Children with Autism Spectrum Disorders and Serious Behavioral Problems / Cristan A. FARMER in Journal of Autism and Developmental Disorders, 42-6 (June 2012)
PermalinkPsychometric characteristics of the aberrant behavior checklist in a well-defined sample of youth with autism Spectrum disorder / Megan NORRIS in Research in Autism Spectrum Disorders, 62 (June 2019)
PermalinkRisperidone Dosing in Children and Adolescents with Autistic Disorder: A Double-Blind, Placebo-Controlled Study / Justine M. KENT in Journal of Autism and Developmental Disorders, 43-8 (August 2013)
PermalinkSensitivity of the modified Children’s Yale–Brown Obsessive Compulsive Scale to detect change: Results from two multi-site trials / Lawrence SCAHILL in Autism, 20-2 (February 2016)
PermalinkThe Repetitive Behavior Scale-Revised: Independent Validation in Individuals with Autism Spectrum Disorders / Kristen S. L. LAM in Journal of Autism and Developmental Disorders, 37-5 (May 2007)
PermalinkTrial Design Challenges When Combining Medication and Parent Training in Children with Pervasive Developmental Disorders / Lawrence SCAHILL in Journal of Autism and Developmental Disorders, 39-5 (May 2009)
PermalinkUsing qualitative methods to guide scale development for anxiety in youth with autism spectrum disorder / Karen E. BEARSS in Autism, 20-6 (August 2016)
PermalinkValidity of the Aberrant Behavior Checklist in Children with Autism Spectrum Disorder / Aaron J. KAAT in Journal of Autism and Developmental Disorders, 44-5 (May 2014)
Permalink